Amidst the Pandemic of COVID-19; Jennifer Jayde’s Newest Book The Awakening: A Guide to Spiritually Awaken Your Highest Self, Intuitive Connection, and Deepest Purpose is Helping Those Discover Their Purpose
August 24, 2020 04:00 ET
|
Jennifer Jayde
VANCOUVER, BC, CANADA, Aug. 24, 2020 (GLOBE NEWSWIRE) -- Jennifer Jayde, an internationally, two time bestselling and multiple award-winning Author, International Speaker, and Worldwide Alignment...
Award-Winning TV Personality Cindy Ashton’s New Book is Released: LIBERATE YOUR VOICE: How to Trust Your Power in a World That Shuts You Down
August 13, 2020 04:00 ET
|
Cindy Ashton Global LLC
New York, NY, Aug. 13, 2020 (GLOBE NEWSWIRE) -- Cindy Ashton, the Award-Winning TV host of Cindy Uncorked, has launched a new book, Liberate Your Voice: How to Trust Your Power in a World that Shuts...
‘League of Innovators’ Builds an Online Learning Platform to Discover Entrepreneurship for Youth and Educators
May 25, 2020 11:00 ET
|
League of Innovators
VANCOUVER, British Columbia, May 25, 2020 (GLOBE NEWSWIRE) -- League of Innovators (LOI), a national charity dedicated to providing young people with the much-needed support and resources to launch...
Axsome Therapeutics to Host Investor R&D Call with Key Opinion Leaders Focusing on AXS-07 and the Unmet Needs in the Acute Treatment of Migraine
November 21, 2019 07:00 ET
|
Axsome Therapeutics, Inc.
Company to host conference call on Monday, November 25 at 9:00 AM Eastern NEW YORK, Nov. 21, 2019 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage...
Axsome Therapeutics Announces Results of MINDSET Physician Survey Affirming Unmet Need and Favorable Profile of AXS-07 in the Acute Treatment of Migraine
October 28, 2019 07:05 ET
|
Axsome Therapeutics, Inc.
Majority of physicians indicate improved efficacy is most significant unmet need in the acute treatment of migraine Majority of physicians would be more likely to prescribe AXS-07 over current and...
Axsome Therapeutics Announces Continued Progress in Clinical Development of AXS-07 for the Acute Treatment of Migraine
October 28, 2019 07:00 ET
|
Axsome Therapeutics, Inc.
Enrollment in MOMENTUM Phase 3 migraine trial of AXS-07 in patients with history of inadequate response nearly complete; on track for topline results in 4Q 2019 First patient dosed in new INTERCEPT...